Updates of Overactive Bladder in Pediatrics

키워드

참고문헌 (103)

1. Bakker E, "Voiding habits and wetting in a population of 4,332Belgian schoolchildren aged between 10 and 14 years", Scand J Urol Nephrol, 36, pp.354~362 (2002)
2. Bloom DA, "Toilet habits and continence in children : an opportunity sampling in search of normal parameters", J Urol, 149, pp.1087~1090 (1993)
3. Sureshkumar P, "Daytime urinary incontinence in primary school children : a population-based survey", J Pediatr, 137, pp.814~818 (2000)
4. Sureshkumar P, "A population based study of 2,856 school-age children with urinary incontinence", J Urol, 181, pp.808~815 (2009)
5. Vaz GT, "Prevalence of lower urinary tract symptoms in school-age children", Pediatr Nephrol, 27, pp.597~603 (2012)
6. Feldman AS, "Diagnosis and management of dysfunctional voiding", Curr Opin Pediatr, 18, pp.139~147 (2006)
7. Tekgul S, "EAU-ESPU guidelines recommendations for daytime lower urinary tract conditions in children", Eur J Pediatr, 179, pp.1069~1077 (2020)
8. Franco I, "Pediatric overactive bladder syndrome : pathophysiology and management", Paediatr Drugs, 9, pp.379~390 (2007)
9. Ramsay S, "Overactive bladder in children", Can Urol Assoc J, 11(1-2Suppl1), pp.S74~S79 (2017)
10. Beckel JM, "Neurophysiology of the lower urinary tract", Handb Exp Pharmacol, (202), pp.149~169 (2011)
11. Hall JE, "Guyton and hall textbook of medical physiology" (2020), Elsevier Health Sciences
12. Michel MC, "Basic mechanisms of urgency : preclinical and clinical evidence", Eur Urol, 56, pp.298~307 (2009)
13. Bael A, "The relevance of urodynamic studies for Urge syndrome and dysfunctional voiding : a multicenter controlled trial in children", J Urol, 180, pp.1486~1493 (2008)
14. Franco I, "Overactive bladder in children", Nat Rev Urol, 13, pp.520~532 (2016)
15. Iguchi N, "Early life voiding dysfunction leads to lower urinary tract dysfunction through alteration of muscarinic and purinergic signaling in the bladder", Am J Physiol Renal Physiol, 315, pp.F1320~F1328 (2018)
16. Chung JM, "Prevalence and associated factors of overactive bladder in Korean children 5-13 years old : a nationwide multicenter study", Urology, 73, pp.63~67 (2009)
17. Fowler CJ, "A decade of functional brain imaging applied to bladder control", Neurourol Urodyn, 29, pp.49~55 (2010)
18. Yamaguchi O, "Beta3-adrenoceptors in urinary bladder", Neurourol Urodyn, 26, pp.752~756 (2007)
19. Drake MJ, "Neural control of the lower urinary and gastrointestinal tracts : supraspinal CNS mechanisms", Neurourol Urodyn, 29, pp.119~127 (2010)
20. Santos JD, "Bladder and bowel dysfunction in children : an update on the diagnosis and treatment of a common, but underdiagnosed pediatric problem", Can Urol Assoc J, 11(1-2 Suppl 1), pp.S64~S72 (2017)
21. Israel Franco, "Treatment of Lower Urinary Tract Symptoms in Children With Constipation Using Tegaserod Therapy", UroToday International Journal, 03(03) (2010), Digital Science Press (Urotoday International Journal)[DOI]
22. Blankstein U, "Altered brain structure in irritable bowel syndrome : potential contributions of pre-existing and disease-driven factors", Gastroenterology, 138, pp.1783~1789 (2010)
23. Milsom I, "Global prevalence and economic burden of urgency urinary incontinence : a systematic review", Eur Urol, 65, pp.79~95 (2014)
24. Logan BA, "Voiding dysfunction related to adverse childhood experiences and neuropsychiatric disorders", J Pediatr Urol, 10, pp.634~638 (2014)
25. Griffiths D, "Brain control of normal and overactive bladder", J Urol, 174, pp.1862~1867 (2005)
26. Griffiths D, "Bladder control, urgency, and urge incontinence:evidence from functional brain imaging", Neurourol Urodyn, 27, pp.466~474 (2008)
27. Pezzone MA, "A model of neural cross-talk and irritation in the pelvis : implications for the overlap of chronic pelvic pain disorders", Gastroenterology, 128, pp.1953~1964 (2005)
28. Ustinova EE, "Colonic irritation in the rat sensitizes urinary bladder afferents to mechanical and chemical stimuli : an afferent origin of pelvic organ cross-sensitization", Am J Physiol Renal Physiol, 290, pp.F1478~F1487 (2006)
29. Ustinova EE, "Sensitization of pelvic nerve afferents and mast cell infiltration in the urinary bladder following chronic colonic irritation is mediated by neuropeptides", Am J Physiol Renal Physiol, 292, pp.F123~F130 (2007)
30. Wein AJ, "Campbell-Walsh urology" (2012), Saunders
31. Wyndaele M, "Mechanisms of pelvic organ crosstalk: 1. Peripheral modulation of bladder inhibition by colorectal distention in rats", J Urol, 190, pp.765~771 (2013)
32. Franco I, "Functional bladder problems in children: pathophysiology, diagnosis, and treatment", Pediatr Clin North Am, 59, pp.783~817 (2012)
33. Herz D, "Dysfunctional elimination syndrome as an etiology of idiopathic urethritis in childhood", J Urol, 173, pp.2132~2137 (2005)
34. Berger MY, "Value of abdominal radiography, colonic transit time, and rectal ultrasound scanning in the diagnosis of idiopathic constipation in children: a systematic review", J Pediatr, 161, pp.44~50.e1-2 (2012)
35. Farhat W, "The dysfunctional voiding scoring system : quantitative standardization of dysfunctional voiding symptoms in children", J Urol, 164(3 Pt 2), pp.1011~1015 (2000)
36. Akbal C, "Dysfunctional voiding and incontinence scoring system : quantitative evaluation of incontinence symptoms in pediatric population", J Urol, 173, pp.969~973 (2005)
37. Bower WF, "PinQ: a valid, reliable and reproducible quality-of-life measure in children with bladder dysfunction", J Pediatr Urol, 2, pp.185~189 (2006)
38. Nelson CP, "Incontinence Symptom Index-Pediatric : development and initial validation of a urinary incontinence instrument for the older pediatric population", J Urol, 178(4 Pt 2), pp.1763~1767 (2007)
39. Achenbach TM, "The Child Behavior Checklist and related forms for assessing behavioral", emotional problems and competencies, 2000, pp.21, 265~271
40. Lewis SJ, "Stool form scale as a useful guide to intestinal transit time", Scand J Gastroenterol, 32, pp.920~924 (1997)
41. Douglas A. Drossman, "Functional Gastrointestinal Disorders: History, Pathophysiology, Clinical Features, and Rome IV", Gastroenterology, 150(6), pp.1262~1279.e2 (2016), Elsevier BV[DOI]
42. Butler RJ, "Children’s notions about enuresis and the implications for treatment", Scand J Urol Nephrol Suppl, 163, pp.39~47 (1994)
43. Franco I, "Homsy Y. Pediatric incontinence : evaluation and clinical management" (2015), Wiley-Blackwell;
44. Wiener JS, "Long-term efficacy of simple behavioral therapy for daytime wetting in children", J Urol, 164(3 Pt 1), pp.786~790 (2000)
45. Pekbay Y, "The effects of pelvic floor muscle therapy on symptoms, voiding, and pelvic floor muscle activity parameters in children with overactive bladder", Neurourol Urodyn, 38, pp.1430~1442 (2019)
46. Qi W, "The effect of biofeedback treatment for children with non-neurogenic voiding dysfunction : a systematic review and meta-analysis", Neurourol Urodyn, 41, pp.868~883 (2022)
47. Andersson KE, "Prospective pharmacologic therapies for the overactive bladder", Ther Adv Urol, 1, pp.71~83 (2009)
48. -1,3-benzodioxole-2,2-dicarboxylate (CL-316243)on bladder micturition reflex in spontaneously hypertensive rats, "J Pharmacol Exp Ther", 2008, 178~185
49. Tyagi P, "Mirabegron, a β3-adrenoceptor agonist for the potential treatment of urinary frequency, urinary incontinence or urgency associated with overactive bladder", IDrugs, 13, pp.713~722 (2010)
50. Khullar V, "Efficacy and tolerability of mirabegron, a β(3)-adrenoceptor agonist, in patients with overactive bladder: results from a randomised European-Australian phase 3 trial", Eur Urol, 63, pp.283~295 (2013)
51. 김우중, "Efficacy and Safety of Propiverine in Children with Overactive Bladder", Investigative and Clinical Urology, 53(4), pp.275~279 (2012), 대한비뇨의학회[DOI]
52. Bolduc S, "Prospective open label study of solifenacin for overactive bladder in children", J Urol, 184(4 Suppl), pp.1668~1673 (2010)
53. Hoebeke P, "Solifenacin for therapy resistant overactive bladder", J Urol, 182(4 Suppl), pp.2040~2044 (2009)
54. Lopez Pereira P, "Trospium chloride for the treatment of detrusor instability in children", J Urol, 170, pp.1978~1981 (2003)
55. Maman K, "Comparative efficacy and safety of medical treatments for the management of overactive bladder : a systematic literature review and mixed treatment comparison", Eur Urol, 65, pp.755~765 (2014)
56. Kay GG, "Antimuscarinic drugs for overactive bladder and their potential effects on cognitive function in older patients", J Am Geriatr Soc, 53, pp.2195~2201 (2005)
57. Soliman MG, "Efficacy and safety of mirabegron versus solifenacin as additional therapy for persistent OAB symptoms after tamsulosin monotherapy in men with probable BPO", World J Urol, 39, pp.2049~2054 (2021)
58. Reinberg Y, "Therapeutic efficacy of extended release oxybutynin chloride, and immediate release and long acting tolterodine tartrate in children with diurnal urinary incontinence", J Urol, 169, pp.317~319 (2003)
59. Van Arendonk KJ, "Frequency of wetting is predictive of response to anticholinergic treatment in children with overactive bladder", Urology, 67, pp.1049~1053 (2006)
60. Youdim K, "Preliminary study of the safety and efficacy of extended-release oxybutynin in children", Urology, 59, pp.428~432 (2002)
61. Van Arendonk KJ, "Improved efficacy of extended release oxybutynin in children with persistent daytime urinary incontinence converted from regular oxybutynin", Urology, 68, pp.862~865 (2006)
62. Nijman R, "ICS course 3: urinary incontinence in children", International UroGynecological Association 34th Annual Meeting (2004)
63. Chapple CR, "Randomized double-blind, active-controlled phase 3 study to assess 12-month safety and efficacy of mirabegron, a β(3)-adrenoceptor agonist, in overactive bladder", Eur Urol, 63, pp.296~305 (2013)
64. Bolduc S, "The use of tolterodine in children after oxybutynin failure", BJU Int, 91, pp.398~401 (2003)
65. Podnar S, "Lower urinary tract dysfunction in patients with peripheral nervous system lesions", Handb Clin Neurol, 130, pp.203~224 (2015)
66. Nijman RJ, "Tolterodine treatment for children with symptoms of urinary urge incontinence suggestive of detrusor overactivity: results from 2 randomized, placebo controlled trials", J Urol, 173, pp.1334~1339 (2005)
67. Medhi B, "Comparison of tolterodine with standard treatment in pediatric patients with non-neurogenic dysfunctional voiding", over active bladder : a systematic review, 2013, pp.57, 343~353
68. Malhotra B, "Dose-escalating study of the pharmacokinetics and tolerability of fesoterodine in children with overactive bladder", J Pediatr Urol, 8, pp.336~342 (2012)
69. Newgreen D, "Long-Term Safety and Efficacy of Solifenacin in Children and Adolescents with Overactive Bladder", J Urol, 198, pp.928~936 (2017)
70. Newgreen D, "Solifenacin in children and adolescents with overactive bladder : results of a phase 3 randomised clinical trial", Eur Urol, 71, pp.483~490 (2017)
71. Blais AS, "Prospective pilot study of mirabegron in pediatric patients with overactive bladder", Eur Urol, 70, pp.9~13 (2016)
72. Marschall-Kehrel D, "Treatment with propiverine in children suffering from nonneurogenic overactive bladder and urinary incontinence : results of a randomized placebo-controlled phase 3 clinical trial", Eur Urol, 55, pp.729~736 (2009)
73. Sacco E, "Mirabegron : a review of recent data and its prospects in the management of overactive bladder", Ther Adv Urol, 4, pp.315~324 (2012)
74. Nitti VW, "Results of a randomized phase III trial of mirabegron in patients with overactive bladder", J Urol, 189, pp.1388~1395 (2013)
75. Frazier EP, "Does cyclic AMP mediate rat urinary bladder relaxation by isoproterenol?", J Pharmacol Exp Ther, 313, pp.260~267 (2005)
76. Uchida H, "Involvement of cyclic AMP-dependent and-independent mechanisms in the relaxation of rat detrusor muscle via beta-adrenoceptors", Eur J Pharmacol, 518, pp.195~202 (2005)
77. Kobayashi H, "Involvement of BK(Ca)channels in the relaxation of detrusor muscle via betaadrenoceptors", Eur J Pharmacol, 404, pp.231~238 (2000)
78. Morin F, "Dual therapy for refractory overactive bladder in children : a prospective open-label study", J Urol, 197, pp.1158~1163 (2017)
79. Kim JK, "β3-Adrenoceptor agonist for the treatment of bladder dysfunction in children : a systematic review and meta-analysis", J Urol, 207, pp.524~533 (2022)
80. Gamé X, "Botulinum toxin-A(Botox)intradetrusor injections in children with neurogenic detrusor overactivity", neurogenic overactive bladder : a systematic literature review, 2009, pp.5, 156~164
81. Riccabona M, "Botulinum-A toxin injection into the detrusor : a safe alternative in the treatment of children with myelomeningocele with detrusor hyperreflexia", J Urol, 171(2 Pt 1), pp.845~848 (2004)
82. Pascali MP, "Effects of botulinum toxin type a in the bladder wall of children with neurogenic bladder dysfunction : a comparison of histological features before and after injections", J Urol, 185(6 Suppl), pp.2552~2557 (2011)
83. Figueroa V, "Single-center experience with botulinum toxin endoscopic detrusor injection for the treatment of congenital neuropathic bladder in children: effect of dose adjustment, multiple injections, and avoidance of reconstructive procedures", J Pediatr Urol, 10, pp.368~373 (2014)
84. Hoebeke P, "The effect of botulinum-A toxin in incontinent children with therapy resistant overactive detrusor", J Urol, 176, pp.328~330 (2006)
85. Lahdes-Vasama TT, "Urodynamic assessment of children treated with botulinum toxin A injections for urge incontinence : a pilot study", Scand J Urol Nephrol, 45, pp.397~400 (2011)
86. Marte A, "Effectiveness of botulinum-A toxin for the treatment of refractory overactive bladder in children", Eur J Pediatr Surg, 20, pp.153~157 (2010)
87. Apostolidis A, "Recommendations on the use of botulinum toxin in the treatment of lower urinary tract disorders and pelvic floor dysfunctions : a European consensus report", Eur Urol, 55, pp.100~119 (2009)
88. Greer T, "Ten years of experience with intravesical and intrasphincteric onabotulinumtoxinA in children", J Pediatr Urol, 12, pp.94.e1~94.e6 (2016)
89. Bower WF, "A pilot study of the home application of transcutaneous neuromodulation in children with urgency or urge incontinence", J Urol, 166, pp.2420~2422 (2001)
90. Hoebeke P, "Transcutaneous neuromodulation for the urge syndrome in children : a pilot study", J Urol, 166, pp.2416~2419 (2001)
91. Roth TJ, "Sacral neuromodulation for the dysfunctional elimination syndrome : a single center experience with 20 children", J Urol, 180, pp.306~311 (2008)
92. De Gennaro M, "Percutaneous tibial nerve neuromodulation is well tolerated in children and effective for treating refractory vesical dysfunction", J Urol, 171, pp.1911~1913 (2004)
93. Fernandez N, "Neurostimulation therapy for non-neurogenic overactive bladder in children : a meta-analysis", Urology, 110, pp.201~207 (2017)
94. Groen LA, "Sacral neuromodulation with an implantable pulse generator in children with lower urinary tract symptoms : 15-year experience", J Urol, 188, pp.1313~1317 (2012)
95. Beksac AT, "Postvoidal residual urine is the most significant non-invasive diagnostic test to predict the treatment outcome in children with non-neurogenic lower urinary tract dysfunction", J Pediatr Urol, 12, pp.215.e1~215.e8 (2016)
96. Bower WF, "The transition of young adults with lifelong urological needs from pediatric to adult services : an international children’s continence society position statement", Neurourol Urodyn, 36, pp.811~819 (2017)
97. Barroso U Jr, "Posterior tibial nerve stimulation vs parasacral transcutaneous neuromodulation for overactive bladder in children", J Urol, 190, pp.673~677 (2013)
98. Sillén U, "Effects of transcutaneous neuromodulation(TENS)on overactive bladder symptoms in children : a randomized controlled trial", J Pediatr Urol, 10, pp.1100~1105 (2014)
99. Patidar N, "Transcutaneous posterior tibial nerve stimulation in pediatric overactive bladder : a preliminary report", J Pediatr Urol, 11, pp.351~ (2015)
100. Boudaoud N, "Management of refractory overactive bladder in children by transcutaneous posterior tibial nerve stimulation : a controlled study", J Pediatr Urol, 11, pp.138.e1~138.e10 (2015)
101. Quintiliano F, "Transcutaneous parasacral electrical stimulation vs oxybutynin for the treatment of overactive bladder in children : a randomized clinical trial", J Urol, 193(5 Suppl), pp.1749~1753 (2015)
102. Veiga ML, "Parasacral transcutaneous electrical nerve stimulation for overactive bladder in constipated children : the role of constipation", J Pediatr Urol, 12, pp.396.e1~396.e6 (2016)
103. Borch L, "Transcutaneous electrical nerve stimulation combined with oxybutynin is superior to monotherapy in children with urge incontinence: a randomized, placebo controlled study", J Urol, 198, pp.430~435 (2017)

관련 논문AI추천